Literature DB >> 3617397

Pathologic features of abdominal and thoracic paragangliomas in F344/N rats.

L B Hall, K Yoshitomi, G A Boorman.   

Abstract

Seventeen paragangliomas were identified in a retrospective review of 200 NTP/NCI carcinogenicity studies in F344/N rats that served either as control or treated animals. Most tumors were grossly visible and located in the retroperitoneum adjacent to the vertebrae and aorta near the kidneys. Three microscopically detected paragangliomas were found at the base of the heart. Microscopically, neoplastic cells were in nests separated by reticulin fibers and capillaries. Argyrophil granules were in the cytoplasm of the retroperitoneal and mediastinal paravertebral tumors. Dense granules were found in the one tumor examined ultrastructurally. Some tumors had areas of necrosis and tumor emboli were present in the lumen of the abdominal aorta and vena cava adjacent to the tumor with metastases present in pulmonary vessels. The incidence of retroperitoneal neoplasms was 3 times more frequent in male than in female F344/N rats.

Entities:  

Mesh:

Year:  1987        PMID: 3617397     DOI: 10.1177/030098588702400405

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  2 in total

1.  Proceedings of the 2017 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Famke Aeffner; Dinesh S Bangari; Torrie A Crabbs; Stacey Fossey; Shayne C Gad; Wanda M Haschek; Jessica S Hoane; Kyathanahalli Janardhan; Ramesh C Kovi; Gail Pearse; Lyn M Wancket; Erin M Quist
Journal:  Toxicol Pathol       Date:  2017-11-07       Impact factor: 1.902

2.  A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+/- rats.

Authors:  James F Powers; Brent Cochran; James D Baleja; Hadley D Sikes; Andrew D Pattison; Xue Zhang; Inna Lomakin; Annette Shepard-Barry; Karel Pacak; Sun Jin Moon; Troy F Langford; Kassi Taylor Stein; Richard W Tothill; Yingbin Ouyang; Arthur S Tischler
Journal:  Endocr Relat Cancer       Date:  2020-06       Impact factor: 5.678

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.